Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model
暂无分享,去创建一个
P. Lacouture | J. Brown | G. H. Johnson | M. Shi | G. B. Curtis | P. Clark | R. Taylor | R. O'Callaghan | G. Johnson
[1] S. Derby,et al. Systemic Opioid Therapy for Chronic Cancer Pain , 1998 .
[2] E. Kalso,et al. Controlled-release oxycodone and morphine in cancer related pain , 1997, Pain.
[3] E. Bruera,et al. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study , 1997, PAIN.
[4] M. Levy. Pharmacologic treatment of cancer pain. , 1996, The New England journal of medicine.
[5] M. Suarez‐Almazor,et al. Opioid rotation for toxicity reduction in terminal cancer patients. , 1995, Journal of pain and symptom management.
[6] P. Staats,et al. Current management of pain in patients with cancer. , 1994, Oncology.
[7] Jeanette. Mitchell,et al. Analgesic efficacy and potency of two oral controlled‐release morphine preparations , 1993, Clinical pharmacology and therapeutics.
[8] W. Beaver,et al. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain , 1991, Clinical pharmacology and therapeutics.
[9] A. Aitkenhead,et al. Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers. , 1984, British journal of anaesthesia.
[10] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .